Davies MA - Search Results

1

AKT1 Activation Promotes Development of Melanoma Metastases.

Cho JH, Robinson JP, Arave RA, Burnett WJ, Kircher DA, Chen G, Davies MA, Grossmann AH, VanBrocklin MW, McMahon M, Holmen SL. Cho JH, et al. Among authors: davies ma. Cell Rep. 2015 Nov 3;13(5):898-905. doi: 10.1016/j.celrep.2015.09.057. Epub 2015 Oct 22. Cell Rep. 2015. PMID: 26565903 Free PMC article.

2

A novel AKT3 mutation in melanoma tumours and cell lines.

Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB. Davies MA, et al. Br J Cancer. 2008 Oct 21;99(8):1265-8. doi: 10.1038/sj.bjc.6604637. Epub 2008 Sep 23. Br J Cancer. 2008. PMID: 18813315 Free PMC article.

3

Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase.

Ding Z, Liang J, Li J, Lu Y, Ariyaratna V, Lu Z, Davies MA, Westwick JK, Mills GB. Ding Z, et al. Among authors: davies ma. PLoS One. 2010 Mar 26;5(3):e9910. doi: 10.1371/journal.pone.0009910. PLoS One. 2010. PMID: 20361045 Free PMC article.

4

Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells.

Gopal YN, Deng W, Woodman SE, Komurov K, Ram P, Smith PD, Davies MA. Gopal YN, et al. Among authors: davies ma. Cancer Res. 2010 Nov 1;70(21):8736-47. doi: 10.1158/0008-5472.CAN-10-0902. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959481 Free PMC article.

5

Prognostic factors for survival in melanoma patients with brain metastases.

Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P, Bedikian A. Davies MA, et al. Cancer. 2011 Apr 15;117(8):1687-96. doi: 10.1002/cncr.25634. Epub 2010 Oct 19. Cancer. 2011. PMID: 20960525 Free article.

6

Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.

Bedikian AY, Wei C, Detry M, Kim KB, Papadopoulos NE, Hwu WJ, Homsi J, Davies M, McIntyre S, Hwu P. Bedikian AY, et al. Am J Clin Oncol. 2011 Dec;34(6):603-10. doi: 10.1097/COC.0b013e3181f9456a. Am J Clin Oncol. 2011. PMID: 21150567

7

Emerging insights into the molecular biology of brain metastases.

Chen G, Davies MA. Chen G, et al. Among authors: davies ma. Biochem Pharmacol. 2012 Feb 1;83(3):305-14. doi: 10.1016/j.bcp.2011.09.012. Epub 2011 Sep 17. Biochem Pharmacol. 2012. PMID: 21946085 Review.

8

Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition.

Deng W, Gopal YN, Scott A, Chen G, Woodman SE, Davies MA. Deng W, et al. Among authors: davies ma. Pigment Cell Melanoma Res. 2012 Mar;25(2):248-58. doi: 10.1111/j.1755-148X.2011.00950.x. Epub 2012 Jan 12. Pigment Cell Melanoma Res. 2012. PMID: 22171948

9

NRAS mutation status is an independent prognostic factor in metastatic melanoma.

Jakob JA, Bassett RL Jr, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. Jakob JA, et al. Among authors: davies ma. Cancer. 2012 Aug 15;118(16):4014-23. doi: 10.1002/cncr.26724. Epub 2011 Dec 16. Cancer. 2012. PMID: 22180178 Free PMC article.

10

The role of the PI3K-AKT pathway in melanoma.

Davies MA. Davies MA. Cancer J. 2012 Mar-Apr;18(2):142-7. doi: 10.1097/PPO.0b013e31824d448c. Cancer J. 2012. PMID: 22453015 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

666 results

Search Page

Filters